Effectiveness of two methods for informing schizophrenic patients about neuroleptic medication.
作者信息
Kleinman I, Schachter D, Jeffries J, Goldhamer P
机构信息
Department of Psychiatry, University of Toronto, Ontario, Canada.
出版信息
Hosp Community Psychiatry. 1993 Dec;44(12):1189-91. doi: 10.1176/ps.44.12.1189.
PMID:7907571
Abstract
摘要
相似文献
1
Effectiveness of two methods for informing schizophrenic patients about neuroleptic medication.两种向精神分裂症患者告知抗精神病药物信息的方法的有效性。
Hosp Community Psychiatry. 1993 Dec;44(12):1189-91. doi: 10.1176/ps.44.12.1189.
2
Informed consent and tardive dyskinesia. Long-term follow-up.知情同意与迟发性运动障碍。长期随访。
J Nerv Ment Dis. 1996 Sep;184(9):517-22. doi: 10.1097/00005053-199609000-00001.
3
Tardive dyskinesia and informed consent: myths and realities.迟发性运动障碍与知情同意：误区与现实
Bull Am Acad Psychiatry Law. 1982;10(2):77-88.
4
Informed consent and tardive dyskinesia.知情同意与迟发性运动障碍
Am J Psychiatry. 1989 Jul;146(7):902-4. doi: 10.1176/ajp.146.7.902.
5
Tardive dyskinesia, impaired recall, and informed consent.迟发性运动障碍、记忆受损与知情同意。
J Clin Psychiatry. 1985 Oct;46(10):434-5.
6
The effect of psychopathology on the ability of schizophrenic patients to give informed consent.精神病理学对精神分裂症患者做出知情同意能力的影响。
J Nerv Ment Dis. 1994 Jun;182(6):360-2. doi: 10.1097/00005053-199406000-00009.
7
[Patient knowledge regarding tardive dyskinesia].[患者关于迟发性运动障碍的知识]
Nervenarzt. 2006 Mar;77(3):333-7. doi: 10.1007/s00115-005-1897-6.
8
Consent to neuroleptic medication for schizophrenia: clinical, ethical and legal issues.精神分裂症使用抗精神病药物的同意：临床、伦理和法律问题。
Br J Psychiatry. 1996 May;168(5):540-4. doi: 10.1192/bjp.168.5.540.
9
Informing patients about tardive dyskinesia.向患者告知迟发性运动障碍。
Arch Gen Psychiatry. 1985 Sep;42(9):866-71. doi: 10.1001/archpsyc.1985.01790320034005.
10
Consent to treatment.治疗同意书。
Br J Psychiatry. 1996 Sep;169(3):382-3. doi: 10.1192/bjp.169.3.382b.
引用本文的文献
1
Facilitating Informed Permission/Assent/Consent in Pediatric Clinical Trials.促进儿科临床试验中的知情同意/同意/同意
Paediatr Drugs. 2019 Aug;21(4):205-214. doi: 10.1007/s40272-019-00347-5.
2
Psychoeducation for schizophrenia.精神分裂症的心理教育
Cochrane Database Syst Rev. 2011 Jun 15;2011(6):CD002831. doi: 10.1002/14651858.CD002831.pub2.
3
The impact of informing psychiatric patients about their medication: a systematic review.告知精神科患者其所用药物的影响：一项系统综述
Pharm World Sci. 2006 Dec;28(6):329-41. doi: 10.1007/s11096-006-9054-2. Epub 2007 Jan 10.
4
[Patient knowledge regarding tardive dyskinesia].[患者关于迟发性运动障碍的知识]
Nervenarzt. 2006 Mar;77(3):333-7. doi: 10.1007/s00115-005-1897-6.
5
Emerging empirical evidence on the ethics of schizophrenia research.关于精神分裂症研究伦理的新实证证据。
Schizophr Bull. 2006 Jan;32(1):47-68. doi: 10.1093/schbul/sbj012. Epub 2005 Oct 19.
6
Sexually transmitted disease prevention services for female chronically mentally ill patients.针对女性慢性精神病患者的性传播疾病预防服务。
Community Ment Health J. 1995 Aug;31(4):303-15. doi: 10.1007/BF02207518.
Zotero 插件